By: Cassidy Delamarter, University Communications and Marketing
Researchers at the USF Health Morsani College of Medicine, located at the University of South Florida, successfully tested a protein that has the potential to aid in the development of a protein-based therapy for patients with ALS, a progressive nervous system disease, also known as Lou Gehrig鈥檚 disease, that affects nerve cells in the brain and spinal cord.
Published in , the study examines the effects of apolipoprotein A1, a 鈥済ood cholesterol鈥� on endothelial cells, the li